About INCOG BioPharma Services
INCOG BioPharma Services is a company based in United States founded in 2020 by Cory Lewis and Tedd Green.. INCOG BioPharma Services has raised $86.63 million across 5 funding rounds. INCOG BioPharma Services offers products and services including Drug Development Services, Manufacturing Services, and Analytical and Quality Control. INCOG BioPharma Services operates in a competitive market with competitors including Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences and ApiJect, among others.
- Headquarter United States
- Founders Cory Lewis, Tedd Green
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Incog Biopharma Services, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$86.63 M (USD)
in 5 rounds
-
Latest Funding Round
$42.86 M (USD), Series C
May 14, 2024
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of INCOG BioPharma Services
INCOG BioPharma Services offers a comprehensive portfolio of products and services, including Drug Development Services, Manufacturing Services, and Analytical and Quality Control. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assists in developing injectable drug products for market acceleration
Manufactures injectable drugs using advanced facilities and quality controls
Provides testing for drug safety and compliance in pharmaceutical processes
Funding Insights of INCOG BioPharma Services
INCOG BioPharma Services has successfully raised a total of $86.63M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $42.86 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $42.9M
-
First Round
First Round
(03 Sep 2020)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series C - INCOG BioPharma Services | Valuation |
investors |
|
| Apr, 2022 | Amount | Series B - INCOG BioPharma Services | Valuation |
investors |
|
| Apr, 2022 | Amount | Debt – Conventional - INCOG BioPharma Services | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by INCOG BioPharma Services
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - INCOG BioPharma Services
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Incog Biopharma Services Comparisons
Competitors of INCOG BioPharma Services
INCOG BioPharma Services operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences and ApiJect, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Generic injectable drugs are manufactured across therapeutic segments.
|
|
| domain | founded_year | HQ Location |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| domain | founded_year | HQ Location |
Developer and manufacturer of pharmaceutical products
|
|
| domain | founded_year | HQ Location |
Nasal spray drug products are developed, manufactured, and commercialized.
|
|
| domain | founded_year | HQ Location |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| domain | founded_year | HQ Location |
Diversified research services for clinical solutions are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Incog Biopharma Services
Frequently Asked Questions about INCOG BioPharma Services
When was INCOG BioPharma Services founded?
INCOG BioPharma Services was founded in 2020.
Where is INCOG BioPharma Services located?
INCOG BioPharma Services is headquartered in United States.
Who is the current CEO of INCOG BioPharma Services?
Cory Lewis is the current CEO of INCOG BioPharma Services. They have also founded this company.
Is INCOG BioPharma Services a funded company?
INCOG BioPharma Services is a funded company, having raised a total of $86.63M across 5 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on Sep 03, 2020.
What does INCOG BioPharma Services do?
INCOG BioPharma Services was founded in 2020 in the United States as a contract development and manufacturing organization. Emphasis is placed on the production of injectable drug products within the biopharmaceutical sector. Services encompass drug product manufacturing for clients, with operations based domestically. The company was co-founded by Cory Lewis, serving as CEO, and Tedd Green, serving as COO, supporting pharmaceutical development needs.
Who are the top competitors of INCOG BioPharma Services?
INCOG BioPharma Services's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.
What products or services does INCOG BioPharma Services offer?
INCOG BioPharma Services offers Drug Development Services, Manufacturing Services, and Analytical and Quality Control.